Share on StockTwits

Anacor Pharmaceuticals (NASDAQ:ANAC) CEO David P. Perry sold 15,000 shares of the stock on the open market in a transaction that occurred on Wednesday, February 5th. The shares were sold at an average price of $17.00, for a total value of $255,000.00. Following the completion of the transaction, the chief executive officer now directly owns 426,306 shares in the company, valued at approximately $7,247,202. The transaction was disclosed in a filing with the SEC, which is available at this link.

Anacor Pharmaceuticals (NASDAQ:ANAC) traded down 1.93% during mid-day trading on Wednesday, hitting $16.80. The stock had a trading volume of 463,648 shares. Anacor Pharmaceuticals has a 1-year low of $3.00 and a 1-year high of $23.04. The stock’s 50-day moving average is $18.22 and its 200-day moving average is $13.08. The company’s market cap is $684.5 million.

Anacor Pharmaceuticals, Inc is a biopharmaceutical company focused on discovering, developing and commercializing small-molecule therapeutics derived from its boron chemistry platform.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.